Pathology-Parkinson's Disease

Pathology-Parkinson's Disease
I. Definition & Epidemiology:

Definition: Parkinson's disease is a neurodegenerative disorder. Clinically, it's characterized by parkinsonism (a group of motor symptoms); histologically (microscopically), it's defined by neuronal loss in the brain and the presence of Lewy bodies (abnormal protein aggregates) concentrated in the substantia nigra. Crucially, parkinsonism itself is not diagnostic of Parkinson's Disease.
Epidemiology: Primarily affects the elderly. Prevalence is approximately 1% in individuals over 60 years old.

II. Aetiology (Causes):

Mostly Unknown: The cause of most Parkinson's cases remains unclear.
Genetic Factors (Rare Cases): Rarely, inherited mutations in the PARK1 gene (chromosome 4), which codes for α-synuclein (a protein component of Lewy bodies), are implicated.

III. Pathogenesis (Disease Mechanism):

Dopamine Deficiency: Neurons in the substantia nigra project to the putamen and globus pallidus (basal ganglia structures crucial for movement). These neurons release dopamine, a neurotransmitter essential for controlling movement. In Parkinson's, dopamine release is significantly reduced.
Movement Disorder: The lack of dopamine leads to the characteristic movement disorders.

IV. Presentation (Symptoms):

Parkinsonism: The classic triad of symptoms includes:
- Tremor: Involuntary shaking.
- Rigidity: Stiffness and resistance to movement.
- Bradykinesia: Slowness of movement.
Important Note: Parkinsonism can result from various causes (drugs, toxins, infections, trauma) and isn't solely indicative of Parkinson's disease.

V. Macroscopic & Microscopic Findings:

Macroscopy (Gross Examination): Shows pallor (loss of color) in the substantia nigra and locus ceruleus (brain regions).
Histopathology (Microscopic Examination): Reveals:
- Loss of pigmented neurons in the substantia nigra.
- Presence of Lewy bodies within remaining neurons.

VI. Prognosis & Treatment:

Treatment: Dopamine-replacement therapies can alleviate parkinsonism symptoms. However, these treatments do not slow or stop the disease's progression.
Variable Progression: The rate of disease progression varies significantly between individuals.

Kembara Xtra